medigraphic.com
SPANISH

Cardiovascular and Metabolic Science

ISSN 2954-3835 (Electronic)
ISSN 2683-2828 (Print)
Antes Revista Mexicana de Cardiología

Ver Revista Mexicana de Cardiología


  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • Policies
    • General Editorial Policies
    • Manuscript Review Policies
    • Ethical Policies
    • Open access policies
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number 1

<< Back Next >>

Cardiovasc Metab Sci 2026; 37 (1)

WHO 2025 HIV guideline: Integrating cardiometabolic care into HIV services

Abiola-Adepoju, Victor1; Abdulrahim, Abdulrakib2; Jamil, Safayet3
Full text How to cite this article 10.35366/122888

DOI

DOI: 10.35366/122888
URL: https://dx.doi.org/10.35366/122888

Language: English
References: 5
Page: 7-8
PDF size: 289.26 Kb.


Key words:

HIV care, diabetes, health policy, health equity, global health.

ABSTRACT

     

The World Health Organization (WHO)'s 2025 human immunodeficiency virus (HIV) service delivery guideline recognizes that the epidemic is entering a new era marked by ageing, multimorbidity, and limited resources.1 Although global Antiretroviral Therapy (ART) coverage now reaches 31.6 million people, only 73% of People living with HIV (PLHIV) achieve viral suppression.2 Increasing life expectancy increases vulnerability to chronic comorbidities. In sub-Saharan Africa, 5-10% of PLHIV have diabetes, and 20-25% have hypertension. A meta-analysis of 10,916 participants across East Africa found hypertension prevalence at 19.75%, with alcohol use, diabetes, and longer HIV duration as key predictors.3 Traditional HIV clinics, structured for infectious disease management, remain poorly equipped for lifelong chronic care. Without addressing hypertension and diabetes, cardiovascular risk will escalate, ultimately threatening viral suppression and the hard-won gains of the HIV response.

Evidence from sub-Saharan Africa demonstrates that integrating HIV and Non-Communicable Disease (NCD) care is both feasible and cost-effective. In South Africa, the Central Chronic Medicine Dispensing and Distribution program, launched in 2014, enables stable clients to collect ART, along with medicines for hypertension and diabetes, at community pick-up points.4 Patients benefit from reduced travel time, shorter queues, and less stigma, while providers note decongested clinics and greater efficiency. In Uganda and Tanzania, the INTE-AFRICA pragmatic cluster-randomized trial followed more than 7,000 patients with HIV, diabetes, or hypertension.5 Integrated management achieved retention rates above 89% among NCD patients and maintained HIV viral suppression above 95%, demonstrating non-inferiority to vertical care. The economic evaluation confirmed significant cost savings, as single-clinic management of multiple conditions reduced staffing demands and overheads. Patients also valued the convenience of fewer clinic visits. Together, these findings highlight integrated care as an efficient, patient-centered strategy for resource-limited settings.

To scale integrated care, investments are needed in equipment, supply chains, and human resources. Policies enabling task sharing with nurses and community health workers must expand beyond HIV services to include blood pressure and glucose management. Economic analyses suggest that integration can improve efficiency and equity for clients and health systems. Yet HIV funding is shrinking: 2024 resources for the AIDS response were US$18.7 billion, 17% below the US$21.9 billion needed.2 As donors retreat and national budgets dwindle, integrated chronic disease services can maximize impact per dollar spent. Now is the time for ministries, donors, and implementers to align HIV programs with universal health coverage and non-communicable disease strategies, thereby protecting the hard-won gains of the HIV response.


REFERENCES

  1. World Health Organization. WHO guideline on HIV service delivery: updated guidance on the integration of diabetes, hypertension and mental health services, and interventions to support adherence to antiretroviral therapy. Geneva: World Health Organization; 2025. Available in: https://www.who.int/publications/i/item/9789240113879

  2. UNAIDS. Global HIV & AIDS statistics — Fact sheet 2024. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2025. Available in: https://www.unaids.org/en/resources/fact-sheet

  3. Tegegne KD, Adela GA, Kassie GA, Mengstie MA, Seid MA, Zemene MA et al. Prevalence and factors associated with hypertension among peoples living with HIV in East Africa, a systematic review and meta-analysis. BMC Infect Dis. 2023; 23 (1): 724. doi: 10.1186/s12879-023-08679-x.

  4. Bogart LM, Shazi Z, MacCarthy S, Mendoza-Graf A, Wara NJ, Zionts D et al. Implementation of South Africa's central chronic medicine dispensing and distribution program for HIV treatment: a qualitative evaluation. AIDS Behav. 2022; 26 (8): 2600-2612. doi: 10.1007/s10461-022-03602-y.

  5. Kivuyo S, Birungi J, Okebe J, Wang D, Ramaiya K, Ainan S et al. Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trial. Lancet. 2023; 402 (10409): 1241-1250. doi: 10.1016/S0140-6736(23)01573-8.



AFFILIATIONS

1 MD, MPH, Department of HIV and Infectious Diseases, Jhpiego, an affiliate of Johns Hopkins University. Abuja, Nigeria. ORCID: 0000-0001-8379-1001

2 BSc, Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia. Selangor, Malaysia. ORCID: 0000-0002-2939-7086

3 MPH, Department of Public Health, Daffodil International University, Bangladesh. Department of Public and Community Health, Faculty of Medicine and Health Sciences, Frontier University, Garowe, Somalia. ORCID: 0000-0002-2313-4920



Conflict of interests: the authors declare no competing interests.



CORRESPONDENCE

Safayet Jamil. E-mail: safayetkyau333@gmail.com


CC BY-NC-ND

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cardiovasc Metab Sci . 2026;37